Empagliflozin reduces heart failure irrespective of control of blood pressure, low density lipoprotein cholesterol and HbA1c
29 August 2017 (10:05 - 10:55)
Organised by:
Abstract
Slides
About the speaker
St. Michael's Hospital, Toronto (Canada)
6 More presentations in this session
Doctor K. Ozieranski (Warsaw, PL)
Associate Professor J. Siller-Matula (Vienna, AT)
Ms L. Qin (Gaithersburg, US)
Doctor P. Jorgensen (Hellerup, DK)
Doctor J. Yap (Singapore, SG)
Access the full session
The Event
ESC Congress 2017
29 August 2017
10:05 CET
You may be interested in
Congress Presentation
3 September 2019
Congress Session
Congress Presentation
Congress Session
